Tests early palliative care alongside standard treatment for advanced sarcoma
Tests early palliative care with standard treatment in adults newly diagnosed with advanced sarcoma.
Plain-language title generated from the registry record
Registry title: This is a Randomized Study of Early Involvement of Palliative Care Along Side Standard Treatment Versus Standard Treatment Alone in Newly Diagnosed Patients With Advanced or Metastatic Soft Tissue Sarcoma (SARQUALITY)
Key facts
- Where
- Toronto, CanadaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with newly diagnosed advanced or metastatic sarcoma who have not yet had systemic drug treatment for it. It tests adding early palliative care to standard treatment.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Sarcoma confirmed under the microscope that is advanced and cannot be treated with treatment meant to remove all of the disease, or that has spread. ECOG performance status of 0-2 and life expectancy of more than 6 months.
- Earlier treatment
- No earlier systemic treatment with palliative intent for advanced sarcoma.
Main reasons for not taking part
- Thinking problems that make it impossible to give consent or complete questionnaires
- Need for urgent home support or symptom management by a palliative care team
- Already actively followed by a palliative care doctor
- Active psychiatric disorder or drug abuse
- Not enough English to complete the questionnaires
Read by machine on 12 November 2026.
Where in Canada
- Mount Sinai HospitalToronto, CanadaContact: Clinical Trials ManagerTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Mount Sinai Hospital, Canada
- Trial code
- NCT06805669
- Record updated
- 3 February 2025
- Original description
The goal of this study is to learn whether early referral to palliative care improves quality of life for patients with advanced sarcoma.Read full original descriptionShow less
Integrating Early Palliative Care in Advanced SARcoma Patients for Enhanced QUALITY of Life: the SARQUALITY Study
The goal of this study is to learn whether early referral to palliative care improves quality of life for patients with advanced sarcoma.
Participants enrolled in this study will complete quality of life questionnaires before starting their treatment, and every 6 weeks for 24 weeks.
Inclusion: Signed written and voluntary informed consent; Have histologically documented advanced sarcoma, either locally advanced not amenable to curative treatment, or metastatic; Age ≥ 18 years; Have not received any previous systemic treatment with palliative intent for advanced sarcoma; Performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scale; Life expectancy > 6 months; Willing/able to complete questionnaires.
Exclusion: Clinical evidence of cognitive impairment that would preclude the ability to provide informed consent and complete questionnaires, at investigator´s discretion; Active psychiatric disorder or drug abuse; Patient in need of urgent home support services or symptom management through a palliative care team; Patient is being actively followed by a palliative care physician; Insufficient English literacy to complete questionnaires.